BBLG vs. SIENQ, NAOV, EVFM, HGEN, ACOR, AKAN, EVLO, SPRC, SINT, and SCNI
Should you be buying Bone Biologics stock or one of its competitors? The main competitors of Bone Biologics include Sientra (SIENQ), NanoVibronix (NAOV), Evofem Biosciences (EVFM), Humanigen (HGEN), Acorda Therapeutics (ACOR), Akanda (AKAN), Evelo Biosciences (EVLO), SciSparc (SPRC), Sintx Technologies (SINT), and Scinai Immunotherapeutics (SCNI). These companies are all part of the "medical" sector.
Bone Biologics (NASDAQ:BBLG) and Sientra (NASDAQ:SIENQ) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, community ranking, dividends, institutional ownership, analyst recommendations, earnings and valuation.
Bone Biologics has a net margin of 0.00% compared to Sientra's net margin of -65.93%. Sientra's return on equity of 0.00% beat Bone Biologics' return on equity.
Bone Biologics has a beta of 0.24, suggesting that its stock price is 76% less volatile than the S&P 500. Comparatively, Sientra has a beta of 2.18, suggesting that its stock price is 118% more volatile than the S&P 500.
34.3% of Bone Biologics shares are owned by institutional investors. Comparatively, 17.1% of Sientra shares are owned by institutional investors. 13.0% of Bone Biologics shares are owned by company insiders. Comparatively, 1.5% of Sientra shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Bone Biologics and Sientra both received 0 outperform votes by MarketBeat users.
Bone Biologics has higher earnings, but lower revenue than Sientra. Bone Biologics is trading at a lower price-to-earnings ratio than Sientra, indicating that it is currently the more affordable of the two stocks.
In the previous week, Bone Biologics' average media sentiment score of 0.80 beat Sientra's score of 0.00 indicating that Bone Biologics is being referred to more favorably in the media.
Summary
Sientra beats Bone Biologics on 6 of the 11 factors compared between the two stocks.
Get Bone Biologics News Delivered to You Automatically
Sign up to receive the latest news and ratings for BBLG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BBLG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Bone Biologics Competitors List
Related Companies and Tools
